Steven Goldberg, MD (“Dr. G”) works to drive innovation and value in employer population health and precision medicine. He serves as the vice president, medical affairs, population health, chief health officer, health and wellness, at Quest Diagnostics, a position he has held since 2016.
At Quest, he leads employee health, where his team has driven improved member experience, improved population health and bent cost trends for the company’s 46,000 employees and their families. The Medical Affairs division at Quest Diagnostics, for which he serves as the vice president, provides publications support for Quest’s diagnostics pipeline.
Before joining Quest, Steve was senior vice president and chief medical officer at WellCare Health Plans, a provider of government-sponsored managed care services, where he was responsible for leading WellCare’s clinical functions, including enterprise-wide quality and accreditation results. He has previously served in executive medical management roles with Aetna, Express Scripts, Humana and Excellus BCBS.
Steve earned his undergraduate degree from Georgetown University, his MD from Jefferson Medical College, completed the United Health Services Family Medicine Residency in Binghamton, New York, and earned an MBA at Binghamton University. He is board certified in family medicine and maintains a part-time clinical practice. He is a volunteer for No More Red Dots, an initiative dedicated to reducing incidents of gun violence in Louisville, Kentucky.
Read Steve’s statement, “Why I Support the GTMRx Institute”
“There’s accelerating concern about the cost of pharmaceuticals. The industry pipeline is dominated by innovative medicines with companion diagnostics to inform their use.
All stakeholders want to best serve customers and patients, drive best out-comes, best value, and optimize these advances in specialty medicine and precision medicine. To do so, we will need broad consensus among key stakeholders.
We see a great opportunity to partner with the GTMRx Institute in forums that can bring together patients, practitioners, providers, delivery organizations and regulators to drive optimal use of these often life-changing specialty medications and companion diagnostics.”